Open Access: View PDF

DOI: DOI: http://dx.doi.org/10.21088/ijmfnm.2347.999X.5118.14

Abstract

APS in pregnancy is one of the important cause of recurrent pregnancy loss, preclampsia and IUGR. Treatment to be started after confirmation of APS with the help of laboratory and clinical criteria. With the imperfect data that are currently available it is impossible to give evidence based recommendations on how patients with APS should be treated in pregnancy. It is wise to regard pregnancies as being at high risk. Treatment to be started with prepregnancy councelling followed by follow up during pregnancy and treatment.

Keywords: APS; Antiphospholipid Antibody (aPL); Recurrent prgnancy loss; Preclampsia. 

Corresponding Author : Pallavi Y. Untwal, Speciality Medical Officer, Dept. of OBGY, Lokmanya Tilak Municipal Medical College (LTMMC) & Lokmanya Tilak Municipal General Hospital (LTMGH), Sion, Mumbai, Maharashtra 400022, India.